Amphiphilic copolymers based on the copolymerization of hydrophilic and hydrophobic moieties offer versatility in various biomedical material applications. Here, a new biocompatible copolymer of dextran-graft-polybutylmethacrylate is synthesized for the coating of metallic endovascular stents. Coating of metallic surfaces is performed and analyzed by X-ray photoelectron spectroscopy, attenuated total reflection Fourier transform infrared spectroscopy, contact angle measurement, atomic force microscopy and scanning electron microscopy before and after deformation corresponding to stent deployment by a balloon catheter. In the conditions described here, the resulting coating is smooth and uniform with neither cracks nor detachment after stent expansion. Interestingly, surfaces coated with the copolymer greatly improve in vitro adhesion and growth of endothelial cells. This copolymer provides new opportunities for implanted biomaterials.
Introduction
Coronary stent implantation has become a common practice in cardiovascular surgery. However, restenosis remains by far the main complication of this technique. Indeed, the endothelium injury resulting from stenting triggers the migration and proliferation of smooth muscle cells (SMCs) that could lead to in-stent thrombosis and vessel occlusion [1] . The main strategy to avoid thrombus formation is to favor re-endothelialization of the arterial vessel after implantation and to limit SMC proliferation.
Metallic surfaces are not suitable for endothelial cell coverage and they generally induce the adhesion of platelets that stimulate the proliferation of SMCs and lead to restenosis. Surface treatments have been proven effective to modify the biological response [2] . For instance, metallic surface roughness can be decreased by electropolishing [3] to reduce platelet adhesion [4, 5] and to avoid inflammation process. In addition, numerous studies refer to the stents covered by a polymeric layer for improving stents in coronary arteries [6, 7] . This second strategy allowed for a combination of chemical modification, drug release, and roughness reduction of the stent surface. In this context, coating metallic stents by polymeric biocompatible materials has already been described and several polymers were examined, such as polyurethane, poly(ethylene terephthalate), polyorganophosphazene, poly(L-lactic acid), and polydimethylsiloxane [8] . These coatings build up a layer that protects the surrounding tissues against the corrosion products of metallic stents [9, 10] while preserving metal mechanical properties. As cell adhesion also depends on surface wettability [11, 12] , this parameter can be controlled by varying the nature and the composition of the polymeric material [13, 14] .
Among biocompatible polymeric materials, both methacrylate polymers and polysaccharides such as dextran have been widely studied. Previous works demonstrated the non-toxicity of dextran, which was developed as a blood expander and biocompatible hydrogel [15, 16] . On the other hand, polymethacrylates are also currently used in pharmaceutical or biomedical applications. Poly(n-butyl methacrylate) is a particularly interesting methacrylate polymer due to its mechanical properties. It has already demonstrated its efficiency as a biocompatible component for drug eluting stents [17, 18] . In a previous work, we have prepared films made of copolymers with different dextran/n-butyl methacrylate ratios and thus various hydrophilic/hydrophobic properties of the resulting copolymers [19] . It has been established that copolymers made of 89% PBMA and 11% dextran promote endothelial cell growth. These films were also elastic and interesting to evaluate as stent coatings to improve the metallic backbone properties. Therefore, the aim of this work was to investigate the feasibility of homogeneous coating on stainless steel SS316L. In a first step, the coating was performed on disks since their planar configuration allowed X-ray photoelectron spectroscopy (XPS) and atomic force microscopy (AFM) to be performed. Furthermore, coated disks were submitted to a deformation process developed by Mantovani et al. [20] that resulted in a 25% plastic deformation [21] . This procedure mimics the deformation applied to stents during the implantation procedure and allowed the coating stability to be analyzed [22] [23] [24] . In a second step, stents were coated with the copolymer and, due to their three-dimensional geometry, the surface topography was assessed by fluorescence and scanning electron microscopy (SEM). The last step was performed to evaluate in vitro the biological compatibility of the dextran/n-butyl methacrylate copolymer coated on SS316L substrates with vascular smooth muscle cells and endothelial cells.
Materials and methods

Materials
FITC-dextran (70 kg mol
À1 ) (dextran labeled with fluorescein isothiocyanate) and dextran (70 kg mol
À1
) were obtained from SIGMA, France and were dried in a vacuum oven at 60°C for 24 h. Butyl methacrylate monomers were obtained from Acros France and were purified by washing with NaOH (5%), NaCl (20%), followed three times by distilled water. Ceric ammonium nitrate and nitric acid were obtained from Acros. The coating was formed on stainless steel 316L disks (SS316L; Goodfellow, Devon, PA, USA) 12.7 mm in diameter and 0.5 mm thick with the following composition (wt.%): Cr (16.00-18.00), Ni (10.00-14.00), Mo (2.00-3.00), Mn (62.00), Si (61.00), C (60.08), P (60.045), S (60.03) and Fe (balance). The coating was also performed onto SS316L stents with internal expanded diameters of 3.5 mm provided by Guidant (Ireland).
Synthesis of the copolymer
The reactions were carried out in a 1 l five-neck flask equipped with stirrer and condenser. The flask was immersed into a thermostatted oil bath at 40°C and purged by nitrogen gas. Typically, 0.125 g of dextran was dissolved in 500 ml of nitric acid (0.2 M) for 10 min. 5 ml of solution of Ce(IV) dissolved in 0.2 M HNO 3 (2.4 Â 10 -4 mol l
À1
) and 2 g of BMA monomers were simultaneously added. For experiments involving fluorescence microscopy, FITC-dextran was blended with dextran at a mass ratio of 30%. The system was continuously stirred for 40 min; the pH was then raised to 8 by the addition of 10 M NaOH aqueous solution and concentrated in a rotavapor. Methanol was used as a non-solvent to precipitate the polymeric material, which was washed with 50 ml EDTA (10 À2 M) to remove cerium ions. The purified copolymer was frozen at À20°C and lyophilized for 24 h. In order to obtain pure graft copolymer, the resulting product was extracted with acetone in a continuous extraction system, i.e. Soxhlet, for 6 h to remove PBMA homopolymer. The copolymer, which will be designated as Dex-PBMA, was once more lyophilized and weighed. The content of dextran in the copolymer was 11% (w/ w) [19] .
Characterization of the copolymer
Attenuated total reflection infrared spectroscopy was carried out on a Perkin-Elmer 1600 spectrometer using 64 scans. Differential scanning calorimetry (DSC) was performed with a Setaram DSC131 thermal analyzer between À50 and +200°C at a heating rate of 10°C min
À1
. Contact angles were measured with a Krüss DSA 10-Mk2 by deposition of 2 ll water droplets; each sample was submitted to ten measurements. Dynamic mechanical analyses were performed on a DMA Q800 (TA Instruments) on 15 Â 5 Â 0.035 mm films. Measurements were performed at a frequency of 1 Hz, with an amplitude of 5 mm, between À90 and 150°C at a heating rate of 3°C min À1 . Creep test was carried out by suspending a 100-200 g load from the edge of a 15 Â 5 Â 0.035 mm film. Three measurements were taken per sample for two replicates and averaged.
Solubilization of the copolymer and coating of surfaces
The obtained copolymer was dissolved in a mixture of tetrahydrofuran (THF) with H 2 O at a ratio of 92:8 (v:v). SS316L stents were dip-coated by immersion in copolymer solution at 5% w/v, while stainless steel coupons were coated by deposition of a 0.1-1% w/ v copolymer solution. After evaporating the solvents for 24 h at room temperature in a saturated atmosphere of THF and in the presence of CaCl 2 , samples were air dried for 24 h. All stents were rinsed several times with distilled water and phosphate buffered saline (PBS). Coated stents were mounted over a balloon, and hand-crimped. Dextran did not give any stable coating in aqueous solutions. PBMA coatings were achieved by preparing solutions in THF in the same conditions of concentration as for Dex-PBMA and THF was allowed to evaporate.
Ductility evaluation of coated SS136L disks 2.5.1. Deformation process
The coated coupons were plastically deformed up to 25% using a custom-made small punch test device mounted on a SATEC T20000 testing machine (Instrod, Norwood, MA, USA), as previously described [22, 23] . All deformations were performed at room temperature at a displacement rate of 0.05 mm s À1 and a load of 2200 N. All subsequent analyses were performed on the topmost part of the deformed samples, where the 25% deformation had occurred.
Characterization of the coating
The surface chemical compositions of coated samples before and after deformation were deduced from survey spectra obtained using an X-ray photoelectron spectrometer (XPS-PHI 5600-ci Spectrometer-Physical Electronics, Eden Prairie, MN, USA). These spectra were acquired using the K a line of standard aluminum (K a = 1486.6 eV) X-ray source with charge compensation.
Surface imaging of coated samples, before and after deformation, was carried out using scanning electron microscopy (SEM) on a JEOL JSM35CF (JEOL, Tokyo, Japan) at a beam energy of 15 keV.
The surface topography of coated samples was obtained by atomic force microscopy in tapping mode using a Dimension™ 3100 Atomic Microscope (Veeco, Woodbury, NY, USA) with an etched silicon tip (tip radius < 10 nm). The surface roughness was calculated and expressed as the root mean square roughness parameter (R RMS ) from three areas of 20 Â 20 lm 2 per sample.
Two replicates per sample were used and averaged. Visualization and analysis of the morphology were performed using the WSxM software [25] .
Morphological evaluation of coated stents
Fluorescein isothiocyanate-labeled dextran (FITC-Dextran) in the copolymer was used in order to evaluate the homogeneity and distribution of coatings. The coating was analyzed by fluorescence microscopy using standard fluorescein filters. The morphology of coated stents, before and after balloon expansion, was also investigated by SEM. The samples were mounted on aluminum stubs covered with adhesive conductive carbon tape and coated with a layer of gold/palladium. The micrographs were obtained at 5.0 kV on a Leica 340 scanning electron microscope.
Cell proliferation on the coated surfaces
Endothelial cells (HUVEC-C from ATCC) and vascular smooth muscle cells (VSMC line Rb1 [26] ), were used in this study. Proliferation studies of ECs and SMCs were performed on SS316L disks coated with Dex-PBMA films and on SS316L disks previously exposed to UV at 254 nm for 30 min. Cells were introduced at an initial concentration of 5 Â 10 3 cells cm À2 and cultured in Dulbecco's modified Eagle's medium (DMEM, Gibco) with 4.5 g l À1 of glucose and 2% L-glutamine supplemented with 10% calf serum and 1% of penicillin and streptomycin. For 5 days, the cell layer on each disk was daily washed twice with PBS to remove loose cells. Cells were detached with trypsin/EDTA 0.25/0.02 (w/v), resuspended and counted with a Coulter counter (Coulter Counter ZM). The cell numbers from three disks per tested material were counted and the results of means ± SD from two separate experiments were averaged. Statistical analysis was performed using a Student's ttest, with the following levels of significance:
⁄ P < 0.05, ⁄⁄ P < 0.01, ⁄⁄⁄ P < 0.001. Coated stents were placed on the bottom of a 24-well tissueculture polystyrene plate, and were exposed to UV at 254 nm for 30 min. Bare metal stents were also used as a reference. ECs were directly seeded on the surface of each sample at 5 Â 10 5 cells per stent. Cells were cultured in DMEM (Gibco) with 4.5 g l À1 of glucose and 2% L-glutamine supplemented with 10% calf serum and 1% of penicillin and streptomycin. The cells were incubated at 37°C in air containing 5% CO 2 and in a humidified incubator. After 5 days of incubation, cells were fixed with 10% paraformaldehyde in DMEM at 4°C for 10 min and permeabilized with 0.1% Triton-X 100 for 5 min. Samples were rinsed with PBS and then with PBS 1% BSA for 20 min. The F-actin was stained with red phalloidin FluoProbes 547 (Interchim) diluted to 20% in PBS for 30 min. The nucleus was stained with DAPI (Interchim). All samples were thoroughly washed three times with PBS before examination by fluorescence microscopy.
Results
Synthesis and characterization of the copolymer
Dextran-graft-polybutylmethacrylate copolymer, Dex-PBMA, was synthesized by radical polymerization using cerium in aqueous acidified medium as previously described [19, 26] . Characteristics of Dex-PBMA are summarized in Table 1 . DSC measurements of Dex-PBMA revealed a single glass transition, which is 3°C higher than polybutylmethacrylate. Dex-PBMA (11:89 w/w) is mainly constituted of PBMA and our previous works demonstrated that increasing the proportion of dextran in the copolymer increased the glass transition temperature (T g ) [19] .
Copolymer films were prepared by solubilizing the copolymer in a precise mixture of THF and water (92:8 v/v). Interestingly, none of the parent homopolymers was soluble in this solution. Hydrophilicity of Dex-PBMA films was evaluated and compared to PBMA alone (dextran could not provide any stable film in aqueous media). The presence of 11% of dextran increased the wettability of the surface, with a water contact angle decreasing from 98.9°f or PBMA to 79.4°for Dex-PBMA.
Moreover, Dex-PBMA films were able to withstand important deformations. Creep tests showed a typical viscoelastic behavior and the propensity of the material to stretch. Indeed, more than 200% deformation was achieved before cracking by suspending a 200 g load on a small film (15 Â 5 Â 0.035 mm). As comparison, PBMA was too brittle and could not even be mounted on the testing device. At 37°C, the value of the storage modulus E 0 of the copolymer was 480 MPa, as determined by dynamic mechanical analysis (Fig. 1) . The temperature dependence of tan d showed a maximum at 57°C (Fig. 1). 
Coating of SS316L disks
The coating onto 316L metallic disks was characterized before and after deformation. To obtain a uniform coating able to follow the plastic deformation, copolymer concentrations ranging from 1 to 10 mg ml À1 have been tested. Chemical composition and topography were assessed on coated samples before and after submitting the disks to 25% plastic deformation.
XPS analyses evidenced a similar chemical composition of the surface on samples, whatever the concentration used: 79 ± 1% for C and 21 ± 1% for O. However, the coating homogeneity exhibited differences depending on the initial polymer concentration as shown on AFM pictures (Fig. 2) . Coatings obtained with PBMA or Dex-PBMA at 1 mg ml À1 were rough and less homogeneous compared to those obtained at 5 and 10 mg ml À1 . Indeed, the roughness R RMS for PBMA and Dex-PBMA at 1 mg ml À1 exhibited high values as well as high standard deviation ($40 nm for both values), whereas R RMS of coatings at higher concentrations demonstrated an homogeneous coating: R RMS $7 nm for 5 mg ml À1 and $14-25 nm for 10 mg ml À1 . The deformation procedure was then applied onto coatings prepared with polymer concentrations of 5 and 10 mg ml
À1
. XPS analyses did not exhibit a significant change in the coating chemical composition before and after deformation, and no metallic compounds were detected. This indicates that film delamination or cracks exposed less than 1% of the metallic surface, which corresponds to the XPS sensitivity. In contrast, AFM experiments revealed that the roughness of the coating was increased after deformation, mainly due to slip bands in SS316L induced during the plastic deformation, leading to an R RMS of $160-170 nm (values deduced from 20 Â 20 lm 2 images -data Table 1 Characterizations of the Dex-PBMA copolymer: solubilization tests (S = Soluble; I = Insoluble) in water, THF or THF/water (92/8 v/v). T g were obtained from DSC curves with dextran, PBMA and Dex-PBMA at a heating rate of 10°C min À1 ; contact angle measurements on films of PBMA and Dex-PBMA (no film could be obtained with dextran); FTIR spectroscopy on stents coated with PBMA, dextran or Dex-PBMA. , respectively. SEM images exhibited defects for coatings obtained from 10 mg ml À1 both for PBMA and Dex-PBMA, whereas coatings at 5 mg ml À1 followed the metal deformation (Fig. 3) . Furthermore, it could be noticed that PBMA coating became thinner as the slip bands were clearly visible whereas they were not observed with elastic Dex-PBMA coating.
The thickness of coatings at 10 mg ml À1 has been evaluated from AFM images that exhibited cracks. The estimated values were $350 and $500-600 nm for PBMA and Dex-PBMA, respectively. Despite an apparent thicker film of Dex-PBMA, the cracks are thinner compared to PBMA (Fig. 3) , confirming that Dex-PBMA was more elastic and able to follow the plastic deformation.
Consequently, the previous tests made on flat SS316L samples have permitted the screening of the effect of the polymer concentration on coating thickness compared with its stability to follow the plastic deformation. However, it should be mentioned that the optimal concentration deduced from flat samples could not be directly correlated to the optimal concentration for stent coating. Indeed, the coating procedure was not the same due the sample configuration: expanded 316L stents were dip-coated by immersion in copolymer solution, while stainless steel disks were coated by deposition. In the case of dip-coating, there was loss of material in comparison with the deposition process. The concentration of copolymer solution for dip-coating has been also optimized (data not shown).
Evaluation of the coating on stents
The FTIR spectra of the copolymer coated on stent show a strong peak at 1730 cm À1 , attributed to the stretching mode of the carbonyl groups of PBMA, and another one at 3400 cm À1 , attributed to the hydroxyl groups of dextran. Additional information on the characterization of the stent coating was obtained by SEM. Dex-PBMA coating on metallic stents was clearly visualized by SEM (Fig. 4) . The Dex-PBMA coating on stent is uniform and smooth before (a) and after (b-d) dilatation by an angioplasty balloon. Indeed, the stent expansion did not induce fissures and the cohesion of the Dex-PBMA coating was maintained (Fig. 4b) . Moreover, magnifications made on high-deformation points, as localized in Fig. 4c and d, clearly demonstrated the quality of the copolymer coating. The evaluation of coating was also performed by fluorescence as shown in Fig. 4e , using FITC-labeled dextran in the copolymer. Microscopic analyses of the FITC-Dex-PBMA coated stent after expansion displayed a homogeneous coating, again, without cracks even in highly distorted areas.
In vitro vascular cell compatibility
Proliferation of endothelial cells on non-coated metallic SS316L disks or disks coated with Dex-PBMA was studied in vitro for a period of 5 days, as previously studied for PBMA films [27] . As shown in Fig. 5 , proliferation analysis showed that the endothelial cells seeded on Dex-PBMA films exhibited a 14-fold increased proliferation between day 0 and day 5 (from 5. 3 cells cm À2 after 5 days; 1.1-fold increase). The cell numbers on Dex-PBMA were more than 10 times higher than on noncoated disks (P < 0.005 vs. uncoated disks).
In the same conditions, smooth muscle cell proliferation after 5 days of incubation was very low on Dex-PBMA with a 4.4-fold increase (23 Â 10 3 cells cm
À2
; P < 0.05), and on SS316L with a 2.7-fold increase (14 Â 10 3 cells cm À2 ). Endothelial cells were then seeded directly on stents. After 5 days, cells were stained and examined by fluorescence microscopy. In comparison with an uncoated stent (Fig. 6A) , endothelial cells exhibited high coverage on the stent coated with the Dex-PBMA copolymer (Fig. 6B ).
Discussion
This work demonstrates that the Dex-PBMA copolymer is providing physicochemical characteristics, such as T g and contact angle, close to those obtained with PBMA alone, which can be related to the high content of PBMA in the Dex-PBMA copolymer (11:89%, w:w), although wettability was increased. The mechanical properties demonstrated by this copolymer were dramatically improved by the incorporation of dextran in the composition, especially in terms of elongation of the copolymer films. PBMA films were too brittle to be submitted to the creep test, while Dex-PBMA films could withstand a deformation of as much as 200%. This aspect is of particular importance for stent coating, as the copolymer should exhibit enough viscoeleasticity in order to follow the stent dilatation induced during the implantation procedure (inflation by a balloon catheter).
This study was also able to determine an optimal concentration where the polymer coating of metallic disks remains homogeneous, and does not display any cracks or delamination when submitted to a 25% plastic deformation [21] , as well as minimal roughness of the surface, as displayed by electron microscopy. Moreover, deposition of Dex-PBMA copolymers onto a metallic stent backbone allowed a homogeneous coating to be obtained that could also remain smooth and uniform after expansion by a balloon catheter. This indicated that the Dex-PBMA copolymer coated on a stent has the ability to tolerate the compressive and tensile strains exerted during the stent expansion process. Taken together, these data highlight the extremely interesting elastic properties of Dex-PBMA films, with reference to PBMA alone, and thus show the capability of copolymer to withstand plastic deformation.
On a more biological aspect of Dex-PBMA coating, we were able to demonstrate that these copolymer films could mediate interesting properties for endothelial cells. The endothelial cell level increased on the Dex-PBMA films compared to metallic surfaces in vitro for both metallic disks and on stents coated with the copolymer. These findings are likely to be related to the hydrophilic/hydrophobic balance provided by the Dex-PBMA copolymer and are strongly suggesting that copolymer coating can significantly improve endothelialization and thus provide beneficial effect when implanted in vivo.
Conclusion
The dextran-graft-butymethacrylate (Dex-PBMA) copolymer is a new polymer with a balance of hydrophilic/hydrophobic properties. The Dex-PBMA copolymer exhibits elastic properties and therefore is used here as a coating for stents. First, the results evidence that Dex-PBMA coating is homogeneous and shows excellent mechanical properties after deformation both on SS316L disks and stents. Interestingly, our in vitro data of endothelialization on metallic surfaces reveal a major difference between the polymer-coated and the bare metal disks or stents, the Dex-PBMA copolymer enhancing endothelial cell proliferation. Further biological assessments have to be performed to completely characterize the in vitro behavior of the copolymer. These tunable properties obtained with the copolymer could be of great interest for stent design, but also in various applications of polymeric biomaterials by surface modification of cardiovascular medical devices such as catheters [28] . 
